OLR1 and neoplasm: 15-LOX1 and 15-LOX2 expression was not significantly different in smoker, ex-smoker and non-smoker patients (Fig. 3b), implicating that they may act as tumor suppressors for NSCLCs in both smokers and non-smokers.